Ignite Creation Date:
2025-12-24 @ 7:54 PM
Ignite Modification Date:
2025-12-28 @ 3:29 AM
Study NCT ID:
NCT05982704
Status:
UNKNOWN
Last Update Posted:
2023-08-08
First Post:
2023-08-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Tixagevimab/Cilgavimab and Regdanvimab Efficacy for Treatment of COVID-19
Sponsor:
City Clinical Hospital No.52 of Moscow Healthcare Department
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-08-18
Start Date Type:
ACTUAL
Primary Completion Date:
2022-09-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-11-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-08-07
First Submit QC Date:
None
Study First Post Date:
2023-08-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-07
Last Update Post Date:
2023-08-08
Last Update Post Date Type:
ACTUAL